Table 1.
Anatomical criteria from the instructions for use for AAA endovascular devices approved by the FDA
| Endovascular device | Year of FDA approval |
Neck diameter (mm) |
Neck length (mm) |
Neck angulation (°) |
Iliac neck length (mm) |
Iliac neck diameter (mm) |
|---|---|---|---|---|---|---|
| Ancure™ (EndoVascular Technologies, Inc., USA)* | 1999 | 18–26 | ≥15 | NS | ≥20 | <13.5 |
| AneuRx® (Medtronic Vascular, Inc., USA) | 1999 | 18–25 | ≥10‡ | ≤45 | NS | NS |
| Excluder® (W. L. Gore & Associates, Inc., USA) | 2002 | 19–26 | ≥15 | ≤60 | ≥10 | 10–18.5 |
| Zenith® (Cook Medical Technologies, USA) | 2003 | 18–28 | ≥15 | ≤60 | ≥15 | 10–20 |
| Low-permeability Excluder® (W. L. Gore & Associates, Inc., USA) | 2004 | 19–26 | ≥15 | ≤60 | ≥10 | 10–18.5 |
| Powerlink® (Endologix, Inc., USA) | 2004 | 18–26 | ≥15 | ≤60 | ≥15 | 8–18 |
| Enlarged-neck Zenith® (Cook Medical Technologies, USA) | 2006 | 18–32 | ≥15 | ≤60 | ≥15 | 10–20 |
| Talent® (Medtronic Vascular, Inc., USA) | 2008 | 18–32 | ≥10 | ≤60 | ≥15 | 8–22 |
| Enlarged-neck Powerlink® (Endologix Inc., USA) | 2009 | 18–32 | ≥15 | ≤60 | ≥15 | 10–23 |
| Enlarged-neck Excluder® (W. L. Gore & Associates, Inc., USA) | 2009 | 19–29 | ≥15 | ≤60 | ≥10 | 10–18.5 |
| Endurant® (Medtronic Vascular, Inc., USA) | 2010 | 19–32 | ≥10 | ≤60 | ≥15 | 8–25 |
| Ovation® (Trivascular, Inc, USA) | 2011 | 15.5–30 | ≥7 | 45–60 | ≥10 | 8–20 |
| Fenestrated Zenith® (Cook Medical Technologies, USA) | 2012 | 19–31 | ≥4 | <45 | >30 | 7–21 |
| Aorfx® (Lombard Medical, UK) | 2013 | 19–29 | ≥15 | ≤90 | ≥15 | 9–19 |
*
Device discontinued in 2003.
‡
Changed to ≥15 mm in 2003.
Abbreviations: AAA, abdominal aortic aneurysm; NS, not specified.